Summary & Overview
CPT 43229: Endoscopic Esophageal Tumor Ablation with Dilation
CPT code 43229 denotes endoscopic ablation of one or more esophageal lesions using a flexible endoscope introduced orally; the procedure may include guidewire-assisted serial dilation of the esophagus before and after ablation. This code captures a therapeutic, minimally invasive approach to treating esophageal tumors or obstructive lesions and is relevant for gastroenterology, surgical oncology, and interventional endoscopy services nationwide. Payers commonly covering this service in national analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find clinical and billing context for use of CPT code 43229, including the procedure’s scope and typical settings (endoscopy suite or hospital outpatient/ambulatory surgical center). The publication outlines benchmarks and policy considerations related to coding and coverage, clarifies what the code represents clinically, and highlights common documentation elements necessary for accurate coding. Data not available in the input for specific ICD-10 pairings, detailed payer edits, and associated taxonomies are noted where applicable. This summary is intended to support clinical coders, revenue cycle professionals, and policy analysts seeking a concise national-level overview of CPT code 43229 and its application.
Billing Code Overview
CPT code 43229 describes endoscopic esophageal tumor ablation performed with a flexible endoscope introduced through the mouth into the esophagus. The procedure may include passage of a guidewire and serial dilators to widen the esophagus before and after tumor ablation.
-
Service type: Endoscopic therapeutic procedure involving tumor ablation with possible dilation
-
Typical site of service: Endoscopy suite or hospital-based outpatient/ambulatory surgical center where upper endoscopic therapeutic procedures are performed
Data not available in the input for payers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old male with progressive dysphagia, weight loss, and an obstructing esophageal lesion identified on prior upper endoscopy and imaging. The patient is scheduled for a therapeutic esophagogastroduodenoscopy (EGD) with endoscopic tumor ablation (e.g., argon plasma coagulation, radiofrequency ablation, or photodynamic therapy) and possible esophageal dilation. The procedure is performed in an endoscopy suite or ambulatory surgery center under monitored anesthesia care or general anesthesia. The clinician introduces a flexible endoscope through the mouth into the esophagus, identifies one or more lesions, and performs ablative therapy to devascularize or debulk tumor tissue. If the lumen is narrowed, the provider may pass a guidewire across the stricture and perform graded dilation using dilators or balloon dilators before and/or after ablation to restore luminal patency. Hemostasis is achieved as needed. Post-procedure, the patient is observed for cardiorespiratory stability, bleeding, perforation signs, and ability to tolerate oral intake before discharge with follow-up arranged.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Urgent, but not emergency, service | When the procedure is performed on an urgent basis the same day due to symptomatic obstruction but not an immediate life-threatening emergency. |